Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 08 2023
Historique:
received: 17 02 2023
accepted: 02 08 2023
medline: 23 8 2023
pubmed: 22 8 2023
entrez: 21 8 2023
Statut: epublish

Résumé

Pronounced immune escape by the SARS-CoV-2 Omicron variant has resulted in many individuals possessing hybrid immunity, generated through a combination of vaccination and infection. Concerns have been raised that omicron breakthrough infections in triple-vaccinated individuals result in poor induction of omicron-specific immunity, and that prior SARS-CoV-2 infection is associated with immune dampening. Taking a broad and comprehensive approach, we characterize mucosal and blood immunity to spike and non-spike antigens following BA.1/BA.2 infections in triple mRNA-vaccinated individuals, with and without prior SARS-CoV-2 infection. We find that most individuals increase BA.1/BA.2/BA.5-specific neutralizing antibodies following infection, but confirm that the magnitude of increase and post-omicron titres are higher in the infection-naive. In contrast, significant increases in nasal responses, including neutralizing activity against BA.5 spike, are seen regardless of infection history. Spike-specific T cells increase only in infection-naive vaccinees; however, post-omicron T cell responses are significantly higher in the previously-infected, who display a maximally induced response with a highly cytotoxic CD8+ phenotype following their 3

Identifiants

pubmed: 37604803
doi: 10.1038/s41467-023-40592-4
pii: 10.1038/s41467-023-40592-4
pmc: PMC10442364
doi:

Substances chimiques

COVID-19 Vaccines 0
Antibodies, Viral 0
Antibodies, Neutralizing 0
Immunoglobulin A 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5065

Informations de copyright

© 2023. Springer Nature Limited.

Références

J Clin Invest. 2022 Dec 1;132(23):
pubmed: 36219482
Cell Rep. 2022 Oct 18;41(3):111496
pubmed: 36261003
Cell. 2022 Nov 10;185(23):4333-4346.e14
pubmed: 36257313
Science. 2022 Aug 19;377(6608):890-894
pubmed: 35857529
Nat Rev Immunol. 2022 Feb;22(2):69-71
pubmed: 35046570
Lancet Microbe. 2022 Jan;3(1):e21-e31
pubmed: 34778853
Clin Infect Dis. 2018 Oct 30;67(10):1523-1532
pubmed: 29672713
Nat Commun. 2023 Aug 21;14(1):5065
pubmed: 37604803
Virus Evol. 2022 Mar 18;8(1):veac023
pubmed: 35502202
Clin Exp Immunol. 2022 Jul 22;209(1):90-98
pubmed: 35522978
Lancet Infect Dis. 2023 Feb;23(2):167-176
pubmed: 36270311
Front Immunol. 2022 Sep 08;13:953949
pubmed: 36159846
Patterns (N Y). 2021 Jan 08;2(1):100178
pubmed: 33511368
Science. 2022 Jul 15;377(6603):eabq1841
pubmed: 35699621
Eur J Immunol. 2022 Aug;52(8):1297-1307
pubmed: 35416291
Science. 2022 Mar 25;375(6587):1406-1411
pubmed: 35133177
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Science. 2022 Nov 11;378(6620):619-627
pubmed: 36264829
N Engl J Med. 2022 Sep 8;387(10):953-954
pubmed: 36044619
PLoS Pathog. 2019 Dec 19;15(12):e1008109
pubmed: 31856206
Nature. 2022 Feb;602(7898):671-675
pubmed: 35016199
EBioMedicine. 2023 Jan;87:104402
pubmed: 36543718
N Engl J Med. 2022 Apr 21;386(16):1532-1546
pubmed: 35249272
Cell. 2021 Apr 15;184(8):2183-2200.e22
pubmed: 33756110
Proc Natl Acad Sci U S A. 2020 Jul 21;117(29):17221-17227
pubmed: 32631992
Nat Commun. 2022 Sep 1;13(1):5135
pubmed: 36050304
Cell. 2021 Nov 11;184(23):5699-5714.e11
pubmed: 34735795
Wellcome Open Res. 2021 Sep 3;6:220
pubmed: 35600250
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Nat Med. 2002 Apr;8(4):379-85
pubmed: 11927944
Lancet Infect Dis. 2022 Jul;22(7):943-945
pubmed: 35691303
N Engl J Med. 2022 Jul 7;387(1):21-34
pubmed: 35704396
Med. 2022 Dec 9;3(12):838-847.e3
pubmed: 36228619
Cell. 2023 May 25;186(11):2392-2409.e21
pubmed: 37164012
Nucleic Acids Res. 2023 Jan 6;51(D1):D1053-D1060
pubmed: 36350643

Auteurs

Hailey Hornsby (H)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

Alexander R Nicols (AR)

Translational and Clinical Research Institute, Immunity, and Inflammation Theme, Newcastle University, Newcastle, UK.

Stephanie Longet (S)

Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Chang Liu (C)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Adriana Tomic (A)

National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
Department of Microbiology, Boston University School of Medicine, Boston, MA, USA.
Department of Biomedical Engineering, Boston University, Boston, MA, USA.
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Adrienn Angyal (A)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

Barbara Kronsteiner (B)

Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
NDM Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.

Jessica K Tyerman (JK)

Translational and Clinical Research Institute, Immunity, and Inflammation Theme, Newcastle University, Newcastle, UK.

Tom Tipton (T)

Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Peijun Zhang (P)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

Marta Gallis (M)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

Piyada Supasa (P)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Muneeswaran Selvaraj (M)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Priyanka Abraham (P)

Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
NDM Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.

Isabel Neale (I)

Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
NDM Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.

Mohammad Ali (M)

Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
NDM Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.

Natalie A Barratt (NA)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

Jeremy M Nell (JM)

Translational and Clinical Research Institute, Immunity, and Inflammation Theme, Newcastle University, Newcastle, UK.
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Lotta Gustafsson (L)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Scarlett Strickland (S)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Irina Grouneva (I)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.

Timothy Rostron (T)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Shona C Moore (SC)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Luisa M Hering (LM)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Susan L Dobson (SL)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Sagida Bibi (S)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.

Juthathip Mongkolsapaya (J)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

Teresa Lambe (T)

Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

Dan Wootton (D)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Victoria Hall (V)

UK Health Security Agency, London, UK.
Faculty of Medicine, Department of Infectious Disease, Imperial College London, London, UK.

Susan Hopkins (S)

UK Health Security Agency, London, UK.
Faculty of Medicine, Department of Infectious Disease, Imperial College London, London, UK.
NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, University of Oxford, Oxford, UK.

Tao Dong (T)

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Eleanor Barnes (E)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre and Oxford University NHS Foundation Trust, Oxford, UK.

Gavin Screaton (G)

Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.

Alex Richter (A)

Institute for Immunology and Immunotherapy, College of Medical and Dental Science, University of Birmingham, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Lance Turtle (L)

NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
Tropical & Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust (member of Liverpool Health Partners), Liverpool, UK.

Sarah L Rowland-Jones (SL)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Miles Carroll (M)

Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Christopher J A Duncan (CJA)

Translational and Clinical Research Institute, Immunity, and Inflammation Theme, Newcastle University, Newcastle, UK.
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Paul Klenerman (P)

Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK. paul.klenerman@ndm.ox.ac.uk.
Oxford NIHR Biomedical Research Centre and Oxford University NHS Foundation Trust, Oxford, UK. paul.klenerman@ndm.ox.ac.uk.
Translational Gastroenterology Unit, University of Oxford, Oxford, UK. paul.klenerman@ndm.ox.ac.uk.

Susanna J Dunachie (SJ)

Peter Medawar Building for Pathogen Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
NDM Centre For Global Health Research, Nuffield Dept. of Clinical Medicine, University of Oxford, Oxford, UK.
Oxford NIHR Biomedical Research Centre and Oxford University NHS Foundation Trust, Oxford, UK.
Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Rebecca P Payne (RP)

Translational and Clinical Research Institute, Immunity, and Inflammation Theme, Newcastle University, Newcastle, UK.

Thushan I de Silva (TI)

Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK. t.desilva@sheffield.ac.uk.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. t.desilva@sheffield.ac.uk.
Vaccines and Immunity Theme, Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia. t.desilva@sheffield.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH